RDDT Reddit | $168.61
-1.2% | 12/20/2024 | Initiated by | Guggenheim | Analyst M. Morris | Buy | $210.00 | N/A | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 12/20/2024 |
KR Kroger | $60.96
-1.4% | 12/19/2024 | Initiated by | Guggenheim | - | Buy | $68.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 12/19/2024 |
BRKR Bruker | $57.39
+0.7% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $72.00 | N/A | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 12/19/2024 |
CYRX Cryoport | $7.69
-2.2% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $11.00 | N/A | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 12/19/2024 |
DHR Danaher | $229.16
+0.3% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $275.00 | N/A | View details for Guggenheim rating of Danaher (NYSE:DHR) on 12/19/2024 |
MRVI Maravai LifeSciences | $5.13
-4.5% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | N/A | View details for Guggenheim rating of Maravai LifeSciences (NASDAQ:MRVI) on 12/19/2024 |
|
NEOG Neogen | $12.12
+0.7% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $15.00 | N/A | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 12/19/2024 |
KROS Keros Therapeutics | $17.12
+0.5% | 12/16/2024 | Downgraded by | Guggenheim | Analyst V. Divan | Buy -> Neutral | | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/16/2024 |
RH RH | $408.23
+2.5% | 12/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $425.00 -> $550.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/13/2024 |
APGE Apogee Therapeutics | $47.50
-0.4% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/12/2024 |
ARVN Arvinas | $18.00
-2.6% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 12/12/2024 |
BWA BorgWarner | $32.00
+0.4% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $41.00 -> $41.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 12/12/2024 |
ANAB AnaptysBio | $13.97
-4.0% | 12/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $90.00 -> $36.00 | N/A | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 12/12/2024 |
WBD Warner Bros. Discovery | $10.44
-2.3% | 12/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $11.00 -> $12.50 | N/A | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 12/12/2024 |
ADCT ADC Therapeutics | $1.99
+1.5% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 12/12/2024 |
LOW Lowe's Companies | $247.37
-0.1% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
M Macy's | $16.65
+2.5% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Macy’s (NYSE:M) on 12/12/2024 |
SPRB Spruce Biosciences | $0.38
-5.6% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 12/12/2024 |
UNFI United Natural Foods | $25.65
-0.9% | 12/12/2024 | Reiterated by | Guggenheim | Analyst J. Heinbockel | Neutral -> Neutral | | N/A | View details for Guggenheim rating of United Natural Foods (NYSE:UNFI) on 12/12/2024 |
BPMC Blueprint Medicines | $90.33
+0.2% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 12/11/2024 |
PEG Public Service Enterprise Group | $85.23
+0.2% | 12/11/2024 | Reiterated by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | | N/A | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 12/11/2024 |
QURE uniQure | $17.43
+2.7% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of uniQure (NASDAQ:QURE) on 12/11/2024 |
TRML Tourmaline Bio | $21.30
+3.1% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
AZO AutoZone | $3,242.23
-0.3% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,350.00 -> $3,750.00 | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/11/2024 |
GEV GE Vernova | $344.92
+0.7% | 12/11/2024 | Target Lowered by | Guggenheim | Analyst J. Osha | Buy -> Buy | $400.00 -> $380.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/11/2024 |
GIII G-III Apparel Group | $33.23
+1.2% | 12/11/2024 | Target Raised by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $36.00 -> $38.00 | N/A | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 12/11/2024 |
PFE Pfizer | $26.71
+1.3% | 12/11/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $33.00 | N/A | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 12/11/2024 |
VFC VF | $22.03
-1.1% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $25.00 -> $27.00 | N/A | View details for Guggenheim rating of VF (NYSE:VFC) on 12/11/2024 |
SIRI Sirius XM | $23.26
+0.8% | 12/11/2024 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 12/11/2024 |
QTTB Q32 Bio | $3.23
-10.0% | 12/11/2024 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | | N/A | View details for Guggenheim rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024 |
TEM Tempus AI | $34.91
-1.8% | 12/9/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $74.00 | N/A | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 12/9/2024 |
TARA Protara Therapeutics | $5.15
-4.5% | 12/6/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for Guggenheim rating of Protara Therapeutics (NASDAQ:TARA) on 12/6/2024 |
CROX Crocs | $113.27
+1.3% | 12/6/2024 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $155.00 | N/A | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 12/6/2024 |
DLTR Dollar Tree | $73.73
+1.1% | 12/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $100.00 | N/A | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 12/6/2024 |
PVH PVH | $107.44
0.0% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $105.00 -> $125.00 | N/A | View details for Guggenheim rating of PVH (NYSE:PVH) on 12/6/2024 |
RBRK Rubrik | $67.17
+1.6% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $52.00 -> $72.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
LULU Lululemon Athletica | $383.49
+1.1% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $350.00 -> $415.00 | N/A | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 12/6/2024 |
FLNC Fluence Energy | $15.94
+4.8% | 12/6/2024 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 12/6/2024 |
TSLA Tesla | $430.60
+2.3% | 12/5/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $156.00 -> $175.00 | N/A | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/5/2024 |
S SentinelOne | $22.43
| 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for Guggenheim rating of SentinelOne (NYSE:S) on 12/5/2024 |
A Simple Trading Strategy You Should Know (Ad) It’s no secret, I love big, juicy options trades.
But when you’re chasing the BIG fish, you gotta have a way to target some steady, consistent returns in there as well.
Check out the $100 Challenge
This Chris Pulver, he’s isolated a way for everyday folks to target $100-$150 a day in the stock market, starting with just $1,000 or so.
And while we cannot promise future returns or against losses, It’s the perfect supplement to more aggressive options strategies…
And right now, everyone needs more cash in this economy. So sign up for the $100 Challenge here |
APTV Aptiv | $59.47
+1.0% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 12/5/2024 |
ORCL Oracle | $169.14
-0.3% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $220.00 | N/A | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 12/5/2024 |
TJX TJX Companies | $121.77
-0.2% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | N/A | View details for Guggenheim rating of TJX Companies (NYSE:TJX) on 12/5/2024 |
FIVE Five Below | $107.69
+1.5% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $125.00 -> $140.00 | N/A | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 12/5/2024 |
FL Foot Locker | $21.55
-3.8% | 12/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $34.00 -> $28.00 | N/A | View details for Guggenheim rating of Foot Locker (NYSE:FL) on 12/5/2024 |
GEV GE Vernova | $344.92
+0.7% | 12/5/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $300.00 -> $400.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/5/2024 |
RH RH | $408.23
+2.5% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $425.00 -> $425.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/4/2024 |
CRM Salesforce | $342.90
-0.2% | 12/4/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 12/4/2024 |
OKTA Okta | $83.60
+0.4% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
WMG Warner Music Group | $31.08
-0.3% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 12/4/2024 |
BASE Couchbase | $15.27
-1.1% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 12/4/2024 |
KROS Keros Therapeutics | $17.12
+0.5% | 12/4/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $96.00 -> $102.00 | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/4/2024 |
LYV Live Nation Entertainment | $132.50
-0.6% | 12/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $146.00 -> $155.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 12/4/2024 |
AZO AutoZone | $3,242.23
-0.3% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/4/2024 |
SNAP Snap | $11.26
-1.2% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $12.11 -> $12.11 | N/A | View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/3/2024 |
RVMD Revolution Medicines | $43.93
-0.3% | 12/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $82.00 -> $87.00 | N/A | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 12/3/2024 |
ABSI Absci | $2.93
-2.0% | 12/3/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 12/3/2024 |
APGE Apogee Therapeutics | $47.50
-0.4% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/3/2024 |
BNTC Benitec Biopharma | $11.24
-1.5% | 12/3/2024 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 12/3/2024 |
PRME Prime Medicine | $2.81
-3.1% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 12/3/2024 |
ZS Zscaler | $185.94
-0.8% | 12/3/2024 | Reiterated by | Guggenheim | - | Neutral | | N/A | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 12/3/2024 |
MRUS Merus | $42.45
+1.4% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $111.00 -> $109.00 | N/A | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 12/3/2024 |
KSS Kohl's | $14.29
+0.8% | 12/2/2024 | Downgraded by | Guggenheim | Analyst R. Drbul | Buy -> Neutral | | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 12/2/2024 |
BBY Best Buy | $85.32
-0.3% | 11/29/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $110.00 -> $105.00 | N/A | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 11/29/2024 |
APGE Apogee Therapeutics | $47.50
-0.4% | 11/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 11/27/2024 |
KSS Kohl's | $14.29
+0.8% | 11/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $26.00 -> $25.00 | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 11/27/2024 |
NJR New Jersey Resources | $46.40
-0.2% | 11/27/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $46.00 -> $49.00 | N/A | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 11/27/2024 |
CPRI Capri | $21.35
+1.2% | 11/26/2024 | Upgraded by | Guggenheim | Analyst R. Drbul | Neutral -> Buy | $30.00 | N/A | View details for Guggenheim rating of Capri (NYSE:CPRI) on 11/26/2024 |
KR Kroger | $60.96
-1.4% | 11/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $61.00 -> $63.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 11/25/2024 |
NXT Nextracker | $36.40
+3.6% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 11/22/2024 |
ROST Ross Stores | $148.68
-0.3% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 11/22/2024 |
WMG Warner Music Group | $31.08
-0.3% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 11/22/2024 |
CPK Chesapeake Utilities | $119.93
+0.3% | 11/22/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $118.00 -> $129.00 | N/A | View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 11/22/2024 |
ESTC Elastic | $102.67
-0.9% | 11/22/2024 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $100.00 -> $120.00 | N/A | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 11/22/2024 |
GAP GAP | $24.01
-0.4% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for Guggenheim rating of GAP (NYSE:GAP) on 11/22/2024 |
SHLS Shoals Technologies Group | $5.47
+6.8% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $8.00 -> $7.00 | N/A | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 11/21/2024 |
TGT Target | $131.92
+0.3% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $180.00 -> $145.00 | N/A | View details for Guggenheim rating of Target (NYSE:TGT) on 11/21/2024 |
AN AutoNation | $171.20
+0.6% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $190.00 -> $189.00 | N/A | View details for Guggenheim rating of AutoNation (NYSE:AN) on 11/21/2024 |
APTV Aptiv | $59.47
+1.0% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $87.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 11/21/2024 |
GNTX Gentex | $29.13
-0.1% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $34.00 | N/A | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 11/21/2024 |
GPI Group 1 Automotive | $418.46
-0.4% | 11/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $420.00 -> $442.00 | N/A | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 11/21/2024 |
LAD Lithia Motors | $360.21
+0.1% | 11/21/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $380.00 -> $418.00 | N/A | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 11/21/2024 |
WMT Walmart | $90.35
-2.0% | 11/20/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $100.00 | N/A | View details for Guggenheim rating of Walmart (NYSE:WMT) on 11/20/2024 |
JACK Jack in the Box | $40.11
-1.5% | 11/20/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $95.00 -> $60.00 | N/A | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 11/20/2024 |
SEDG SolarEdge Technologies | $14.88
+0.7% | 11/20/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | N/A | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/20/2024 |
RBRK Rubrik | $67.17
+1.6% | 11/19/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $48.00 -> $52.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 11/19/2024 |
SBGI Sinclair | $15.87
-1.3% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $18.00 -> $19.00 | N/A | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/19/2024 |
FUN Cedar Fair | $48.77
+0.3% | 11/19/2024 | Target Raised by | Guggenheim | Analyst C. Baker | Buy -> Buy | $52.00 -> $55.00 | N/A | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 11/19/2024 |
IHRT iHeartMedia | $1.92
+2.1% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 11/19/2024 |
ADAP Adaptimmune Therapeutics | $0.59
-2.8% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $4.00 -> $3.00 | N/A | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 11/15/2024 |
A Simple Trading Strategy You Should Know (Ad) It’s no secret, I love big, juicy options trades.
But when you’re chasing the BIG fish, you gotta have a way to target some steady, consistent returns in there as well.
Check out the $100 Challenge
This Chris Pulver, he’s isolated a way for everyday folks to target $100-$150 a day in the stock market, starting with just $1,000 or so.
And while we cannot promise future returns or against losses, It’s the perfect supplement to more aggressive options strategies…
And right now, everyone needs more cash in this economy. So sign up for the $100 Challenge here |
CNTA Centessa Pharmaceuticals | $17.53
+2.2% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $24.00 -> $28.00 | N/A | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 11/15/2024 |
DIS Walt Disney | $111.40
-0.6% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 11/15/2024 |
TPR Tapestry | $64.73
+0.9% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $70.00 | N/A | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 11/15/2024 |
ZNTL Zentalis Pharmaceuticals | $3.18
+6.0% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $8.00 | N/A | View details for Guggenheim rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/15/2024 |
GTN Gray Television | $3.06
+2.3% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $10.00 -> $8.00 | N/A | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 11/12/2024 |
LYV Live Nation Entertainment | $132.50
-0.6% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $146.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 11/12/2024 |
MSGE Madison Square Garden Entertainment | $33.06
-1.0% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $49.00 -> $48.00 | N/A | View details for Guggenheim rating of Madison Square Garden Entertainment (NYSE:MSGE) on 11/12/2024 |
NWSA News | $28.05
+0.7% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $36.00 -> $40.00 | N/A | View details for Guggenheim rating of News (NASDAQ:NWSA) on 11/12/2024 |
PRKS United Parks & Resorts | $54.11
+0.1% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $72.00 -> $70.00 | N/A | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 11/12/2024 |
SMAR Smartsheet | $55.97
-0.1% | 11/11/2024 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 11/11/2024 |
CDTX Cidara Therapeutics | $23.40
+0.8% | 11/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $33.00 | N/A | View details for Guggenheim rating of Cidara Therapeutics (NASDAQ:CDTX) on 11/8/2024 |
SIRI Sirius XM | $23.26
+0.8% | 11/6/2024 | Downgraded by | Guggenheim | Analyst C. Baker | Strong-Buy -> Hold | | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 11/6/2024 |
FOLD Amicus Therapeutics | $9.84
+0.4% | 11/7/2024 | Target Raised by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $13.00 -> $15.00 | N/A | View details for Guggenheim rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
PFGC Performance Food Group | $84.14
-0.3% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $95.00 | N/A | View details for Guggenheim rating of Performance Food Group (NYSE:PFGC) on 11/7/2024 |
SRPT Sarepta Therapeutics | $120.66
+1.4% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $148.00 -> $150.00 | N/A | View details for Guggenheim rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
TNGX Tango Therapeutics | $3.23
+4.2% | 11/7/2024 | Target Lowered by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $18.00 -> $8.00 | N/A | View details for Guggenheim rating of Tango Therapeutics (NASDAQ:TNGX) on 11/7/2024 |
RUN Sunrun | $10.10
+2.3% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunrun (NASDAQ:RUN) on 11/7/2024 |
NOVA Sunnova Energy International | $3.77
+1.9% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 11/7/2024 |
ARRY Array Technologies | $6.10
+8.3% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/7/2024 |
JNJ Johnson & Johnson | $145.27
+0.6% | 11/6/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $156.00 -> $162.00 | N/A | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 11/6/2024 |
MRK Merck & Co., Inc. | $99.37
+1.3% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $137.00 -> $130.00 | N/A | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 11/6/2024 |
RIVN Rivian Automotive | $13.75
-0.6% | 11/6/2024 | Target Lowered by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $21.00 -> $18.00 | N/A | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 11/6/2024 |
ABBV AbbVie | $178.39
+1.6% | 11/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $212.00 -> $221.00 | N/A | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 11/6/2024 |
DAVA Endava | $30.97
+2.2% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $45.00 -> $40.00 | N/A | View details for Guggenheim rating of Endava (NYSE:DAVA) on 11/6/2024 |
ITRI Itron | $108.93
-0.1% | 11/6/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $128.00 -> $135.00 | N/A | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 11/6/2024 |
FOXA FOX | $49.45
-0.2% | 11/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $50.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 11/5/2024 |
KTB Kontoor Brands | $86.57
-0.9% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $80.00 -> $100.00 | Medium | View details for Guggenheim rating of Kontoor Brands (NYSE:KTB) on 11/1/2024 |
ETR Entergy | $75.43
+0.4% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.50 -> $82.50 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/1/2024 |
KYMR Kymera Therapeutics | $40.79
+0.3% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $52.00 | Medium | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 11/1/2024 |
ARGX argenx | $628.32
+0.7% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $585.00 -> $665.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
GSK GSK | $34.06
+1.4% | 10/31/2024 | Downgraded by | Guggenheim | Analyst S. Fernandez | Buy -> Neutral | | Medium | View details for Guggenheim rating of GSK (NYSE:GSK) on 10/31/2024 |
CROX Crocs | $113.27
+1.3% | 10/30/2024 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $182.00 -> $155.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/30/2024 |
EXEL Exelixis | $33.48
+0.6% | 10/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $32.00 -> $33.00 | Medium | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/30/2024 |
FSLR First Solar | $186.36
+2.2% | 10/30/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $368.00 -> $335.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 10/30/2024 |
NFLX Netflix | $911.45
+0.3% | 10/29/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $810.00 -> $825.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/29/2024 |
FUN Cedar Fair | $48.77
+0.3% | 10/29/2024 | Initiated by | Guggenheim | Analyst C. Baker | Buy | $52.00 | Medium | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 10/29/2024 |
GNLX Genelux | $2.30
+1.3% | 10/29/2024 | Initiated by | Guggenheim | Analyst K. Goodwin | Buy | $8.00 | Low | View details for Guggenheim rating of Genelux (NASDAQ:GNLX) on 10/29/2024 |
RL Ralph Lauren | $230.41
+0.1% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $225.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 10/28/2024 |
PVH PVH | $107.44
0.0% | 10/28/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $105.00 | Medium | View details for Guggenheim rating of PVH (NYSE:PVH) on 10/28/2024 |
WMT Walmart | $90.35
-2.0% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $81.00 -> $90.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 10/28/2024 |
VERA Vera Therapeutics | $42.31
-0.7% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $56.00 -> $64.00 | High | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 10/28/2024 |
RVMD Revolution Medicines | $43.93
-0.3% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $82.00 | Medium | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 10/28/2024 |
NEP NextEra Energy Partners | $17.49
-0.7% | 10/28/2024 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | $37.00 -> $22.00 | Medium | View details for Guggenheim rating of NextEra Energy Partners (NYSE:NEP) on 10/28/2024 |
SYRE Spyre Therapeutics | $23.59
-1.1% | 10/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $50.00 -> $65.00 | Medium | View details for Guggenheim rating of Spyre Therapeutics (NASDAQ:SYRE) on 10/25/2024 |
LAD Lithia Motors | $360.21
+0.1% | 10/24/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $350.00 -> $380.00 | Low | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 10/24/2024 |
NEE NextEra Energy | $72.49
+1.1% | 10/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $92.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 10/24/2024 |
TSLA Tesla | $430.60
+2.3% | 10/24/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $153.00 -> $156.00 | Medium | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 10/24/2024 |
MCD McDonald's | $291.29
-0.5% | 10/23/2024 | Downgraded by | Guggenheim | Analyst G. Francfort | Buy -> Neutral | $290.00 -> $285.00 | High | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/23/2024 |
ENPH Enphase Energy | $73.00
+2.2% | 10/23/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $73.00 | Low | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/23/2024 |
ANAB AnaptysBio | $13.97
-4.0% | 10/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $90.00 | Low | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 10/21/2024 |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
RYTM Rhythm Pharmaceuticals | $56.04
-0.1% | 10/21/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $70.00 | High | View details for Guggenheim rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 10/21/2024 |
INFA Informatica | $26.60
-1.0% | 10/18/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Informatica (NYSE:INFA) on 10/18/2024 |
PSTG Pure Storage | $63.80
-0.9% | 10/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $93.00 | High | View details for Guggenheim rating of Pure Storage (NYSE:PSTG) on 10/17/2024 |
GRAL Grail | $18.72
+2.0% | 10/17/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | Medium | View details for Guggenheim rating of Grail (NASDAQ:GRAL) on 10/17/2024 |
SEDG SolarEdge Technologies | $14.88
+0.7% | 10/17/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $10.00 | Low | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 10/17/2024 |
ENPH Enphase Energy | $73.00
+2.2% | 10/17/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/17/2024 |
CVLT Commvault Systems | $156.27
-1.5% | 10/15/2024 | Downgraded by | Guggenheim | Analyst H. Ma | Buy -> Neutral | | High | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 10/15/2024 |
TENX Tenax Therapeutics | $5.49
-2.1% | 10/14/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $16.00 | High | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 10/14/2024 |
NFLX Netflix | $911.45
+0.3% | 10/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $735.00 -> $810.00 | Medium | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/11/2024 |
VCYT Veracyte | $40.99
+0.2% | 10/10/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $40.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 10/10/2024 |
TVTX Travere Therapeutics | $17.15
-0.2% | 10/9/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $23.00 -> $41.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 10/9/2024 |
IONS Ionis Pharmaceuticals | $36.08
+1.3% | 10/9/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $70.00 -> $65.00 | Low | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/9/2024 |
GIII G-III Apparel Group | $33.23
+1.2% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Buy | $36.00 | High | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 10/9/2024 |
DECK Deckers Outdoor | $207.65
-1.6% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Neutral | | Low | View details for Guggenheim rating of Deckers Outdoor (NYSE:DECK) on 10/9/2024 |
CROX Crocs | $113.27
+1.3% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Buy | $182.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/9/2024 |
VST Vistra | $140.79
+0.6% | 10/8/2024 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $133.00 -> $177.00 | Low | View details for Guggenheim rating of Vistra (NYSE:VST) on 10/8/2024 |
TLN Talen Energy | $198.75
+0.8% | 10/8/2024 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $219.00 -> $246.00 | N/A | View details for Guggenheim rating of Talen Energy (NASDAQ:TLN) on 10/8/2024 |
NRG NRG Energy | $92.24
+2.0% | 10/8/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $77.00 -> $118.00 | Medium | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 10/8/2024 |
MBX MBX Biosciences | $20.57
+1.0% | 10/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $44.00 | High | View details for Guggenheim rating of MBX Biosciences (NYSE:MBX) on 10/8/2024 |
META Meta Platforms | $599.85
+2.5% | 10/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $600.00 -> $665.00 | N/A | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/7/2024 |
SN SharkNinja | $95.97
+0.7% | 10/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $100.00 -> $120.00 | Low | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 10/7/2024 |
IMCR Immunocore | $28.14
-0.7% | 10/7/2024 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of Immunocore (NASDAQ:IMCR) on 10/7/2024 |
ZVRA Zevra Therapeutics | $8.58
+1.1% | 10/7/2024 | Initiated by | Guggenheim | Analyst E. Hickman | Buy | $20.00 | High | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/7/2024 |
NXST Nexstar Media Group | $158.22
-0.2% | 10/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $200.00 -> $198.00 | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 10/4/2024 |
HD Home Depot | $392.45
0.0% | 10/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $390.00 -> $450.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 10/4/2024 |
ARRY Array Technologies | $6.10
+8.3% | 10/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $14.00 -> $12.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 10/4/2024 |
ENPH Enphase Energy | $73.00
+2.2% | 10/4/2024 | Target Lowered by | Guggenheim | - | Sell -> Sell | $93.00 -> $90.00 | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/4/2024 |
FWRG First Watch Restaurant Group | $18.88
+1.5% | 10/4/2024 | Target Lowered by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $24.00 -> $20.00 | Medium | View details for Guggenheim rating of First Watch Restaurant Group (NASDAQ:FWRG) on 10/4/2024 |
SO Southern | $83.04
+0.2% | 10/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $93.00 -> $97.00 | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 10/2/2024 |
NKE NIKE | $76.76
-0.2% | 10/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $115.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2024 |
ABSI Absci | $2.93
-2.0% | 10/2/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $10.00 | High | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 10/2/2024 |
BTSG BrightSpring Health Services | $17.40
+0.8% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $15.00 -> $18.00 | Medium | View details for Guggenheim rating of BrightSpring Health Services (NASDAQ:BTSG) on 10/1/2024 |
IGMS IGM Biosciences | $6.51
-5.7% | 10/1/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $25.00 -> $20.00 | Medium | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 10/1/2024 |
MRUS Merus | $42.45
+1.4% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $93.00 -> $111.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 10/1/2024 |
VEEV Veeva Systems | $224.89
+0.3% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $233.00 -> $249.00 | Low | View details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 10/1/2024 |
TTEC TTEC | $4.69
+3.3% | 10/1/2024 | Upgraded by | Guggenheim | Analyst J. Lee | Sell -> Neutral | | Medium | View details for Guggenheim rating of TTEC (NASDAQ:TTEC) on 10/1/2024 |
TKO TKO Group | $141.75
-1.2% | 9/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | Medium | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 9/30/2024 |
ACET Adicet Bio | $0.89
-1.8% | 9/30/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Hold -> Buy | $7.00 | High | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 9/30/2024 |
VSTM Verastem | $3.96
-5.5% | 9/30/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Buy | $13.00 | High | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 9/30/2024 |
ACN Accenture | $358.77
-2.1% | 9/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $380.00 -> $395.00 | Medium | View details for Guggenheim rating of Accenture (NYSE:ACN) on 9/27/2024 |
DT Dynatrace | $54.38
-0.5% | 9/27/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $55.00 -> $64.00 | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 9/27/2024 |
TVTX Travere Therapeutics | $17.15
-0.2% | 9/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $25.00 -> $23.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/27/2024 |
W Wayfair | $45.26
-1.0% | 9/26/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $70.00 -> $70.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 9/26/2024 |
DPZ Domino's Pizza | $426.54
+0.1% | 9/26/2024 | Target Lowered by | Guggenheim | - | Neutral -> Neutral | $485.00 -> $460.00 | Low | View details for Guggenheim rating of Domino’s Pizza (NYSE:DPZ) on 9/26/2024 |
ARGX argenx | $628.32
+0.7% | 9/26/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $585.00 -> $585.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 9/26/2024 |
TXRH Texas Roadhouse | $180.42
-0.5% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $190.00 -> $195.00 | Low | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 9/25/2024 |
PRGS Progress Software | $65.29
-1.6% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $64.00 -> $70.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 9/25/2024 |
PARA Paramount Global | $10.35
-2.9% | 9/25/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $19.00 -> $14.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 9/25/2024 |
AZO AutoZone | $3,242.23
-0.3% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,225.00 -> $3,350.00 | Low | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 9/25/2024 |
FOXA FOX | $49.45
-0.2% | 9/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $44.00 -> $45.00 | Low | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 9/24/2024 |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
GEV GE Vernova | $344.92
+0.7% | 9/24/2024 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $300.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 9/24/2024 |
KROS Keros Therapeutics | $17.12
+0.5% | 9/23/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $96.00 | High | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 9/23/2024 |
SPHR Sphere Entertainment | $37.83
-2.2% | 9/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $58.00 -> $63.00 | Medium | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 9/19/2024 |
SIRI Sirius XM | $23.26
+0.8% | 9/18/2024 | Upgraded by | Guggenheim | Analyst C. Baker | Neutral -> Buy | $30.00 | Medium | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 9/18/2024 |
NUVL Nuvalent | $83.85
-0.4% | 9/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $99.00 -> $105.00 | High | View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 9/16/2024 |
INCY Incyte | $69.84
+1.5% | 9/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $86.00 -> $92.00 | Medium | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 9/16/2024 |
DAVA Endava | $30.97
+2.2% | 9/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $55.00 -> $45.00 | Medium | View details for Guggenheim rating of Endava (NYSE:DAVA) on 9/16/2024 |
TSLA Tesla | $430.60
+2.3% | 9/13/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $134.00 -> $153.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 9/13/2024 |
ORCL Oracle | $169.14
-0.3% | 9/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $185.00 -> $200.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 9/13/2024 |
BNTC Benitec Biopharma | $11.24
-1.5% | 9/12/2024 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $17.00 | High | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 9/12/2024 |
CNTA Centessa Pharmaceuticals | $17.53
+2.2% | 9/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $20.00 -> $24.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 9/11/2024 |
ESTC Elastic | $102.67
-0.9% | 9/11/2024 | Initiated by | Guggenheim | Analyst H. Ma | Buy | $100.00 | Medium | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 9/11/2024 |
PROK ProKidney | $1.69
+11.9% | 9/10/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $6.00 | Medium | View details for Guggenheim rating of ProKidney (NASDAQ:PROK) on 9/10/2024 |
QSR Restaurant Brands International | $66.20
-0.9% | 9/9/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $73.00 -> $74.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 9/9/2024 |
TVTX Travere Therapeutics | $17.15
-0.2% | 9/9/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $25.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/9/2024 |
DLTR Dollar Tree | $73.73
+1.1% | 9/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $150.00 -> $120.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 9/6/2024 |
SMAR Smartsheet | $55.97
-0.1% | 9/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $62.00 | Low | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 9/6/2024 |
OS Onestream | $29.50
-0.5% | 9/4/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $34.00 -> $35.00 | Low | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 9/4/2024 |
TLN Talen Energy | $198.75
+0.8% | 9/4/2024 | Initiated by | Guggenheim | Analyst S. Pourreza | Buy | $169.00 | N/A | View details for Guggenheim rating of Talen Energy (NASDAQ:TLN) on 9/4/2024 |
LULU Lululemon Athletica | $383.49
+1.1% | 8/30/2024 | Target Lowered by | Guggenheim | - | Buy | $525.00 -> $350.00 | Low | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 8/30/2024 |
NBTX Nanobiotix | $2.98
-3.9% | 8/28/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Buy | $12.00 | Low | View details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 8/28/2024 |
RZLT Rezolute | $4.44
+1.1% | 8/27/2024 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $11.00 | Low | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 8/27/2024 |
ROKU Roku | $78.80
-2.2% | 8/23/2024 | Upgraded by | Guggenheim | Analyst M. Morris | Neutral -> Buy | $75.00 | Low | View details for Guggenheim rating of Roku (NASDAQ:ROKU) on 8/23/2024 |
URGN UroGen Pharma | $10.71
+0.7% | 8/22/2024 | Initiated by | Guggenheim | Analyst K. Goodwin | Buy | $40.00 | Low | View details for Guggenheim rating of UroGen Pharma (NASDAQ:URGN) on 8/22/2024 |
OS Onestream | $29.50
-0.5% | 8/19/2024 | Initiated by | Guggenheim | Analyst J. Difucci | Buy | $34.00 | Low | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 8/19/2024 |
WMT Walmart | $90.35
-2.0% | 8/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $81.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 8/16/2024 |
ARRY Array Technologies | $6.10
+8.3% | 8/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $18.00 -> $14.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 8/16/2024 |
LLY Eli Lilly and Company | $796.28
+3.7% | 8/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $884.00 -> $1,030.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 8/16/2024 |
NXT Nextracker | $36.40
+3.6% | 8/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $60.00 -> $55.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 8/16/2024 |
DYN Dyne Therapeutics | $23.91
-0.3% | 8/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $50.00 | Low | View details for Guggenheim rating of Dyne Therapeutics (NASDAQ:DYN) on 8/15/2024 |
GTN Gray Television | $3.06
+2.3% | 8/14/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $10.00 | Low | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 8/14/2024 |
PRAX Praxis Precision Medicines | $77.57
+1.4% | 8/14/2024 | Target Raised by | Guggenheim | Analyst Y. Suneja | Buy -> Buy | $155.00 -> $170.00 | Low | View details for Guggenheim rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/14/2024 |
VIGL Vigil Neuroscience | $1.58
-7.1% | 8/14/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $16.00 | Low | View details for Guggenheim rating of Vigil Neuroscience (NASDAQ:VIGL) on 8/14/2024 |
RVNC Revance Therapeutics | $3.07
-0.6% | 8/12/2024 | Reiterated by | Guggenheim | Analyst S. Fernandez | Buy -> Neutral | | Low | View details for Guggenheim rating of Revance Therapeutics (NASDAQ:RVNC) on 8/12/2024 |
LAD Lithia Motors | $360.21
+0.1% | 8/9/2024 | Upgraded by | Guggenheim | Analyst R. Jewsikow | Neutral -> Buy | $338.00 | Low | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 8/9/2024 |
FLNC Fluence Energy | $15.94
+4.8% | 8/9/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $26.00 | Low | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 8/9/2024 |
BROS Dutch Bros | $52.96
-2.0% | 8/8/2024 | Upgraded by | Guggenheim | Analyst G. Francfort | Neutral -> Buy | | Low | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 8/8/2024 |
LLY Eli Lilly and Company | $796.28
+3.7% | 8/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $855.00 -> $884.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 8/5/2024 |
FND Floor & Decor | $101.93
+0.5% | 8/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $130.00 -> $115.00 | Low | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 8/2/2024 |
ETR Entergy | $75.43
+0.4% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $59.00 -> $64.00 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 8/2/2024 |
ED Consolidated Edison | $89.67
-0.4% | 8/2/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $88.00 -> $91.00 | Low | View details for Guggenheim rating of Consolidated Edison (NYSE:ED) on 8/2/2024 |
BPMC Blueprint Medicines | $90.33
+0.2% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $138.00 | Low | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 8/2/2024 |
REGN Regeneron Pharmaceuticals | $715.13
+1.9% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $1,180.00 -> $1,300.00 | Low | View details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 8/2/2024 |
NET Cloudflare | $111.58
-1.0% | 8/2/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $50.00 -> $57.00 | Low | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 8/2/2024 |
NBIX Neurocrine Biosciences | $136.99
+1.2% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $170.00 -> $180.00 | Low | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 8/2/2024 |
MCD McDonald's | $291.29
-0.5% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $280.00 -> $290.00 | Low | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 8/2/2024 |
KTB Kontoor Brands | $86.57
-0.9% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $80.00 | Low | View details for Guggenheim rating of Kontoor Brands (NYSE:KTB) on 8/2/2024 |
IONS Ionis Pharmaceuticals | $36.08
+1.3% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $64.00 -> $70.00 | Low | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 8/2/2024 |
WW WW International | $1.19
-11.2% | 8/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $6.00 | Low | View details for Guggenheim rating of WW International (NASDAQ:WW) on 8/2/2024 |
W Wayfair | $45.26
-1.0% | 8/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $70.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 8/2/2024 |
VRTX Vertex Pharmaceuticals | $405.27
+2.0% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $450.00 -> $558.00 | Low | View details for Guggenheim rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 8/2/2024 |
META Meta Platforms | $599.85
+2.5% | 8/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $500.00 -> $600.00 | Low | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 8/1/2024 |
MGNX MacroGenics | $3.23
+1.6% | 7/31/2024 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | Low | View details for Guggenheim rating of MacroGenics (NASDAQ:MGNX) on 7/31/2024 |
NOVA Sunnova Energy International | $3.77
+1.9% | 7/26/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $7.00 -> $10.00 | Low | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 7/26/2024 |
FTNT Fortinet | $96.42
-0.8% | 7/29/2024 | Downgraded by | Guggenheim | Analyst R. Mcdonough | Buy -> Neutral | | Low | View details for Guggenheim rating of Fortinet (NASDAQ:FTNT) on 7/29/2024 |
AKAM Akamai Technologies | $96.60
+0.7% | 7/29/2024 | Upgraded by | Guggenheim | Analyst R. Mcdonough | Neutral -> Buy | $128.00 | Low | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 7/29/2024 |
EIX Edison International | $79.72
+0.3% | 7/26/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $80.00 -> $83.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 7/26/2024 |
CMS CMS Energy | $66.67
+0.1% | 7/26/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $66.00 -> $67.00 | Low | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 7/26/2024 |
ARGX argenx | $628.32
+0.7% | 7/26/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $545.00 -> $585.00 | Low | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 7/26/2024 |
SPOT Spotify Technology | $456.29
-1.0% | 7/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $400.00 -> $420.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 7/24/2024 |
